Peter Silberstein is an Oncology physician affiliated with Creighton University. OpenAlex indexes 476 publications with 2,656 citations (h-index 26).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
601 N 30th St
Omaha, NE 681312137
Telephone
402-280-4364Registry record last updated 28 Jul 2008.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- JAZZ PHARMACEUTICALS INC.Program year20258 payments
- Caris MPI, Inc.Program year20251 payment
- Aveo Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
31.2%Kinase inhibitor6%Imatinib Mesylate44%Brukinsa21%Cabometyx18%Sprycel18%Part D<11 patientsAromatase Inhibitor5.8%Anastrozole100%Part D≥20 patients+ 8 more classes in this area
Nervous system
23.5%Opioid Agonist15.8%Oxycodone Hcl38%Morphine Sulfate16%Tramadol Hcl12%Hydromorphone Hcl10%Morphine Sulfate Er10%Fentanyl7%Oxycodone-Acetaminophen7%Part D<11 patientsPhenothiazine5.9%Prochlorperazine Maleate100%Part D≥34 patients+ 1 more class in this area
Metabolism & gastrointestinal
14.9%Serotonin-3 Receptor Antagonist7.6%Ondansetron Odt100%Part D≥47 patientsCorticosteroid5.1%Prednisone100%Part D≥18 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Gastrointestinal manifestations, risk factors, and management in patients with post-transplant lymphoproliferative disorder: A systematic review
World Journal of Transplantation
2022 - Primary anatomical site as a prognostic factor for pleomorphic liposarcoma
Journal of Cancer Research and Clinical Oncology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Beart, MD
Creighton University
Alan Thorson, MD
Creighton University
Aryan Mooss, MD
Creighton University
Ross Bremner, MD
Creighton University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”